Basis Genomic Group

Basis Genomic Group operates within the Medical Testing and Clinical Laboratories sector, specializing in advanced genomic analysis and DNA testing services. Founded to address the growing demand for precision medicine, the company provides a comprehensive suite of diagnostic solutions tailored for cardiology, cosmetology, and dietology. By leveraging high-throughput sequencing technologies, Basis Genomic Group delivers actionable genetic insights that enable corporate clients and individual patients to manage health risks effectively. The firm maintains a robust operational footprint with 500-1,000 employees dedicated to clinical excellence and preventive healthcare innovation.

The organization serves a diverse clientele, including medical clinics, practicing physicians, and private patients, facilitating data-driven health management strategies. Meet Basis Genomic Group's team to understand the leadership and clinical expertise driving their diagnostic capabilities. Their service model integrates complex genetic data into personalized recommendations, ensuring that healthcare providers can offer targeted interventions based on individual genetic profiles. This focus on clinical utility positions the company as a key player in the regional diagnostic market, emphasizing accuracy and accessibility in genomic testing.

With an annual revenue of $70.4M, Basis Genomic Group continues to scale its infrastructure to meet the evolving needs of the healthcare industry. The company maintains a single primary location in Novosibirsk, Russia, serving as the hub for its laboratory operations and research initiatives. By prioritizing technical precision and scalable service delivery, the firm remains committed to advancing the integration of genomics into routine clinical practice and long-term wellness planning.